14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
OPHC vs MRDN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, OptimumBank Holdings, Inc. (OPHC) is the stronger overall head-to-head candidate over MRDN (MRDN) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). OPHC carries a Unified Composite Score of 40.4/100 (SELL) at $8.03 (5.6x Forward P/E, 50.5% operating margin), whereas MRDN carries 51.9/100 (HOLD) at $3.92 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While MRDN currently prints a higher short-term Unified Composite Score (51.9/100 HOLD vs. OPHC 40.4/100 SELL), OPHC captures the overall institutional head-to-head verdict (9–1 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (50.5% vs. N/A operating margin) and revenue trajectory (+51.2% vs. N/A YoY).
Technical & Structure Timing Caution: OPHC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.6); meanwhile MRDN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 14.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OPHC vs MRDN. Trailing 12-month operating profitability (OPHC 50.5% vs MRDN N/A) and valuation multiples (OPHC 5.6x vs MRDN N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ OPHC vs MRDN Key Questions & Quantitative Answers
As of Nov 20, 2026, OptimumBank Holdings, Inc. (OPHC) is the stronger overall head-to-head candidate over MRDN (MRDN) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). OPHC carries a Unified Composite Score of 40.4/100 (SELL) at $8.03 (5.6x Forward P/E, 50.5% operating margin), whereas MRDN carries 51.9/100 (HOLD) at $3.92 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While MRDN currently prints a higher short-term Unified Composite Score (51.9/100 HOLD vs. OPHC 40.4/100 SELL), OPHC captures the overall institutional head-to-head verdict (9–1 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (50.5% vs. N/A operating margin) and revenue trajectory (+51.2% vs. N/A YoY). Technical & Structure Timing Caution: OPHC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.6); meanwhile MRDN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 14.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
OPHC leads the Growth & Scale pillar: OPHC posts +51.2% YoY revenue growth and +67.4% YoY earnings growth on $42M TTM revenue (100.0% gross margin, 50.5% operating margin), compared with MRDN at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, OPHC generates $42M in USD-normalized revenue versus N/A for MRDN. In operating R&D and SG&A reinvestment, OPHC deploys 49.5% of Rev ($21M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for MRDN.
OPHC screens cheaper on headline valuation multiples. OPHC trades at 5.6x Forward P/E, 8.2x Trailing P/E, 1.03x PEG, and 3.0x EV/Revenue (unreported cash flow margin), whereas MRDN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against OPHC (17.5% ROE) versus MRDN (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, OPHC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.60β · 36% Vol realized risk). By comparison, MRDN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.82β · 110% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.